{"title":"西维那潘+化放疗治疗洛杉矶SCCHN:II期临床试验的扩展随访","authors":"Jean Bourhis","doi":"10.2217/vjbm-2023-0010","DOIUrl":null,"url":null,"abstract":"Prof. Jean Bourhis presents the extended follow-up study of the phase II clinical trial of xevinapant + CRT in unresected LA SCCHN.","PeriodicalId":498732,"journal":{"name":"Video journal of biomedicine","volume":"1 10","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Xevinapant + chemoradiotherapy in LA SCCHN: extended follow-up of a phase II clinical trial\",\"authors\":\"Jean Bourhis\",\"doi\":\"10.2217/vjbm-2023-0010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Prof. Jean Bourhis presents the extended follow-up study of the phase II clinical trial of xevinapant + CRT in unresected LA SCCHN.\",\"PeriodicalId\":498732,\"journal\":{\"name\":\"Video journal of biomedicine\",\"volume\":\"1 10\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Video journal of biomedicine\",\"FirstCategoryId\":\"0\",\"ListUrlMain\":\"https://doi.org/10.2217/vjbm-2023-0010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Video journal of biomedicine","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.2217/vjbm-2023-0010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
Jean Bourhis教授介绍了xevinapant+CRT治疗未切除的LA SCCHN的II期临床试验的扩展随访研究。